U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT06904937) titled 'Renal Manifestations During Idiopathic Inflammatory Myopathies' on July 05, 2024.
Brief Summary: There are currently no recommendations regarding treatments for Idiopathic Inflammatory Myopathies (IIM) due to the difficulty in conducting high-powered randomized controlled trials.
Generally speaking, corticosteroids constitute one of the cornerstones of treatment and are, with some exceptions, always used at least in the initial phase of the disease. In general, this involves oral corticosteroid therapy initiated between 0.5 and 1.5 mg/kg/day followed by a gradual decrease after 4 to 6 weeks of treatment. It is generally necessary t...